Detalhe da pesquisa
1.
Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397025
2.
Sialyl Lewis X mediates interleukin-1 beta-induced trophoblast adhesion to endometrial cells during human embryo implantation.
Biol Reprod
; 108(4): 564-574, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648484
3.
Immunotherapy in endometrial cancer.
Int J Gynecol Cancer
; 33(3): 351-357, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878570
4.
Integrating antibody drug conjugates in the management of gynecologic cancers.
Int J Gynecol Cancer
; 33(3): 420-429, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878560
5.
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy.
Int J Gynecol Cancer
; 33(5): 812-822, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707086
6.
Prostaglandin E2 receptor 3 promotes M1 macrophages polarization in unexplained recurrent pregnancy loss.
Biol Reprod
; 106(5): 910-918, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134851
7.
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
Gynecol Oncol
; 165(1): 82-89, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216808
8.
The Impact of the COVID-19 Pandemic on Sexual Health in Cis Women Living in Germany.
J Sex Med
; 19(6): 907-922, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370105
9.
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
Int J Gynecol Cancer
; 32(5): 662-668, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35185017
10.
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancer.
Curr Opin Obstet Gynecol
; 34(1): 28-35, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967812
11.
The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis.
Int J Mol Sci
; 23(10)2022 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628603
12.
A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer.
Gynecol Oncol
; 160(2): 418-426, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243443
13.
Fertility preservation in rare ovarian tumors.
Int J Gynecol Cancer
; 31(3): 432-441, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649010
14.
Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance.
Curr Opin Obstet Gynecol
; 33(1): 19-25, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315700
15.
Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage.
Int J Mol Sci
; 22(17)2021 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502044
16.
Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.
Int J Mol Sci
; 22(16)2021 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445181
17.
Treatment Landscape of Ductal Carcinoma In Situ.
Chirurgia (Bucur)
; 116(5 Suppl): S76-S82, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967314
18.
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers.
Int J Gynecol Cancer
; 30(10): 1608-1618, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928926
19.
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
Int J Gynecol Cancer
; 30(11): 1733-1737, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020204
20.
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.
Int J Gynecol Cancer
; 30(11): 1768-1774, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037105